In one of America's most extensive independent workplace studies, The Timken Company was ranked on a list of top companies committed to recruiting and advancing diversity in the workplace. The ranking is the result of over 223,000 employee interviews and data from 1.5 million comprehensive company reviews.

H&S will commercialize Polyplexus, an open innovation digital platform initially developed for DARPA, focusing on accelerating scientific discovery. H&S aims to expand Polyplexus, making it available to government research sponsors, industry R&D, foundations, entrepreneurs, and academic researchers with the goal of bringing unique talent and innovative ideas to life quickly, efficiently, and with less risk.

Our latest newsletter celebrates growth, innovation, and the incredible community that makes it all possible.

Newsweek and Statistica recognize The Timken Company for their environmental, social, and corporate governance efforts, showcasing a continuous effort towards heightened transparency.

Liquid AI, an MIT spinoff, emerges from stealth mode, on a mission to revolutionize AI models. Backed by $37.5M in seed capital, including support from industry leaders like Stephen Pagliuca, they are developing a new generation of AI foundation models with a commitment to environmental sustainability.

Herzog & Schindler received recognition on the Inc. Business Media annual Power Partner Awards list honoring organizations across the globe that have proven track records supporting entrepreneurs and helping startups grow. The list recognizes firms in marketing and advertising, health and wellness, financial services, legal, logistics, and productivity, as well as other areas of business.

Competition seeks to tap into the diverse community of regional artists to commission an original mural for the iconic façade in the property's Tier Garten.

‍

The report outlines Timken’s progress in building a more efficient and resilient world, including their focus on environmental sustainability in their operations, products, and the industries they serve.  

‍

Renee Wegrzyn was recognized in the Innovators category of Time Magazine's 100 Next List for groundbreaking efforts to advance biomedical innovations, including precision cancer surgery techniques that promise to reshape health outcomes.